Top Story

Patent filed for injectable HBV, liver cancer drug in China

September 18, 2014

Biostar Pharmaceuticals has filed an invention and creation patent application in China for oleanolic acid injection for the treatment of hepatitis B virus infection and liver cancer, according to a news release.

The drug, currently under pharmacological research, passed the preliminary examination of the People’s Republic of China State Intellectual Property Bureau, the release said.

In the Journals

Half of patients with HIV not screened regularly for HCV

September 17, 2014
Researchers from Boston Medical Center have found that although most patients with HIV were screened for hepatitis C virus infection when enrolling into care, only half…
In the Journals

VSL#3 reduced hospitalizations, liver disease severity in cirrhotic patients

September 17, 2014
Hospitalizations and severity of liver disease decreased among patients with cirrhosis assigned the probiotic VSL#3 compared with those receiving placebo in a clinical…

Sovaldi use declined; pharmacy's analysts anticipate rise with release of newer therapies for HCV

September 17, 2014
The rate at which patients have used sofosbuvir to treat hepatitis C virus infection has declined in recent months, according to an analysis performed by the CVS Health…
More News Headlines »
CME
figure

HCV Consults: Volume 1, Number 2

This activity is supported by educational grants from AbbVie and Genentech.

Approved interferon-free therapy has already become entrenched among clinicians for patients with HCV genotypes 2 and…
More »
Meeting News Coverage Video
figure

Tenofovir/entecavir recommended for HBV patients with malignancy

May 16, 2014
CHICAGO — Spilios Manolakopoulos, MD, of the internal medicine and hepatology departments at…
More »
CME
figure

HCV Consults: Volume 1, Number 1

This activity is supported by educational grants from AbbVie and Genentech.

Physicians seldom experience a paradigm shift in disease management as great as that transpiring in HCV therapy. With…
More »